Related Experiment Video
Updated: Jul 27, 2026
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
[Transfer factor as specific immunomodulator in the treatment of moderate-severe atopic dermatitis]
G Flores Sandoval1, J Gómez Vera, M Orea Solano
1Servicio de inmunología y alergia, Hospital Licenciado Adolfo López Mateos, ISSSTE, Florida, México, DF.
Background:
Atopic dermatitis is a skin inflammatory disease which has been associated to high levels of IgE, eosinophiles and change of T lymphocytes. The transfer factor is an immunomodulator active substance and decreases the number of inflammatory cells and the severity of the symptoms of atopic dermatitis.
Objective:
To determine the efficacy of the transfer factor as treatment of moderate and severe atopic dermatitis.
Material And Methods:
Articles related to treatment with transfer factor in the atopic dermatitis were looked up in Medline and EMBASE, and the ones referring to controlled studies in patients with moderate and severe atopic dermatitis in accord to SCORAD.
Results:
We found seven articles with 121 patients and 88 controls demonstrating significant decrease in the symptoms of the SCORAD index, decreased IgE, and eosinophils in patients treated with transfer factor.
Conclusions:
The transfer factor is a choice treatment for moderate and severe atopic dermatitis.
Related Concept Videos
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids